510(k) Report

510(k) · Cleared

Cleared

BD Probe Tec Urine Preservative Transport

K052224510(k) SpecialCleared Sep 12, 200527-day reviewClass II21 CFR 866.3390

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson & CO · LSL Dna-Reagents, Neisseria

Cleared on Sep 12, 2005 as substantially equivalent to K984631 (Becton Dickinson Microbiology Systems, 1999) after a 27-day review. Its family tree reaches back 1 generation to 1999. 1 later device descends from it.

Decided
Sep 12, 2005
Review
27 days
Class
Class II
Product code
LSL
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K984631 (1999). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant clearedK984631 · Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified Dna Assay · Becton Dickinson Microbiology Systems · 1999 · recalled1995200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K984631 · Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified Dna Assay · Becton Dickinson Microbiology Systems · 1999 · recalled0
  1. Root · 1 generation backK984631 Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae…Becton Dickinson Microbiology Systems · 1999 · Recalled
  2. This deviceK052224 BD Probe Tec Urine Preservative TransportBecton, Dickinson & CO · 2005
  3. Descendant · cites it directly · 0 of its ownK080739 Abbott Realtime CT/NG Assay and Multi-Collect Specimen Collection KitAbbott Molecular, Inc. · 2008

Most influential descendants

Showing 1 of 1 · See all
  • K080739Abbott Realtime CT/NG Assay and Multi-Collect Specimen Collection KitAbbott Molecular, Inc. · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K984631Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified Dna…Becton Dickinson Microbiology Systems19992
0 (this device)K052224BD Probe Tec Urine Preservative TransportBecton, Dickinson & CO2005—
+1K080739Abbott Realtime CT/NG Assay and Multi-Collect Specimen Collection KitAbbott Molecular, Inc.2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
FIG. 1 — Lineage of K052224, 1999–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LSL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LSL device

  1. #1 K231329 Aptima Neisseria gonorrhoeae Assayscore 6.7 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K984631Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified Dna Assay
Summary page 1
…Neisseria gonorrhoeae(OC) ProbeTec ET Chlamydia trachomatis(CT) and Amplified DNA Assays (K98463 1) INTENDED USE: gonorrohoeaeAmplified DNA The BD ProbeTecm ET Ch…
Becton Dickinson Microbiology Systems19992

Also cleared against K984631: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K080739Abbott Realtime CT/NG Assay and Multi-Collect Specimen Collection KitAbbott Molecular, Inc.20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K080739 (Abbott Molecular, Inc., 2008) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K984631.

How does its category compare?

All LSL devices

LSL Dna-Reagents, Neisseria: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LSL

1in 2024

2007: 22008: 12009: 32012: 22013: 22014: 32017: 12018: 32024: 1
2007high 3 (2009) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LSL

90in 2018

2009: 62 days median2014: 86 days median2018: 90 days median
2007high 90 (2018) · low 62 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LSL

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LSL

41in 2025

2009: 42010: 12011: 12013: 12014: 42015: 62016: 62017: 102018: 72019: 142020: 32021: 42022: 112023: 192024: 172025: 41
2007high 41 (2025) · low 0 (2007)2025

MAUDE reports naming product code LSL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200936204
20100—01
20110—01
20122—00
20132—01
201438604
20150—06
20160—06
20171—110
201839007
20190—014
20200—03
20210—04
20220—011
20230—019
20241—017
20250—041
20260—0—

What is it indicated for?

The BD ProbeTec ET Chlamydia trachomatis and Neisseria gonorrohoeae Amplified DNA Assays, when tested with the BD ProbeTec ET System, uses Strand Displacement Amplification (SDA) technology for the direct, qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in endocervical swabs, male urethral swabs, and in female and male urine specimens as evidence of infection with C. trachomatis and N. gonorroheae, or of co-infection with…

Read the full statement (126 words)

The BD ProbeTec ET Chlamydia trachomatis and Neisseria gonorrohoeae Amplified DNA Assays, when tested with the BD ProbeTec ET System, uses Strand Displacement Amplification (SDA) technology for the direct, qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in endocervical swabs, male urethral swabs, and in female and male urine specimens as evidence of infection with C. trachomatis and N. gonorroheae, or of co-infection with both C. trachomatis and N. gonorroheae. Specimens may be from symptomatic and asymptomatic females and males. A separate Amplification Control is an option for inhibition testing (BD ProbeTec ET CT/GC/AC Reagent Pack). The BD ProbeTec ET CT/GC assays may be performed using either the BD ProbeTec ET System or a combination of the BD ProbeTec ET System and BD Viper instrument.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K052224: BD Probe Tec Urine Preservative Transport.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K052224

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026